HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
4.030
-0.010 (-0.25%)
At close: Oct 6, 2025, 4:00 PM EDT
4.000
-0.030 (-0.74%)
Pre-market: Oct 7, 2025, 5:53 AM EDT

HCW Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
920446983-
Upgrade
Market Cap Growth
-61.79%-54.91%-35.84%-17.13%--
Upgrade
Enterprise Value
1332394943-
Upgrade
Last Close Price
4.0317.8449.0076.5992.80-
Upgrade
PS Ratio
5.937.7415.5110.22--
Upgrade
PB Ratio
--2.933.271.841.62-
Upgrade
P/TBV Ratio
--3.271.841.62-
Upgrade
EV/Sales Ratio
15.6312.3913.857.31--
Upgrade
Debt / Equity Ratio
-130.62-2.020.480.18-0.04
Upgrade
Asset Turnover
0.030.090.080.13-0.32
Upgrade
Quick Ratio
0.090.180.5910.9915.8710.94
Upgrade
Current Ratio
0.110.190.7311.5217.4412.14
Upgrade
Return on Equity (ROE)
--897.37%-98.23%-33.63%-39.22%-49.60%
Upgrade
Return on Assets (ROA)
-30.41%-62.72%-42.68%-18.79%-24.25%-28.59%
Upgrade
Return on Capital (ROIC)
-162.01%-137.31%-50.27%-19.79%-25.26%-30.38%
Upgrade
Earnings Yield
-248.58%-151.10%-56.72%-21.69%-15.52%-
Upgrade
FCF Yield
-146.56%-72.92%-65.16%-30.08%-13.30%-
Upgrade
Buyback Yield / Dilution
-33.36%-7.97%-0.30%-90.84%-296.07%-10.56%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q